ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

FWBI First Wave BioPharma Inc

2.60
-0.19 (-6.81%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
First Wave BioPharma Inc FWBI 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.19 -6.81% 2.60 13:00:03
개장가 저가 고가 종가 전일 종가
2.78 2.59 2.9872 2.60 2.79
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
24/04/202420:00GLOBEFirst Wave BioPharma Announces Invited Paper for Special..
17/04/202420:00GLOBEFirst Wave BioPharma CEO James Sapirstein to Present at the..
15/04/202420:00GLOBEFirst Wave BioPharma CEO James Sapirstein to Participate in..
18/03/202420:00GLOBEFirst Wave BioPharma Announces Two Abstracts on Celiac..
14/03/202419:00GLOBEFirst Wave BioPharma Announces Completion of Business..
06/03/202407:26EDGAR2Form 8-K - Current report
05/03/202421:00GLOBEFirst Wave BioPharma to Participate In ‘Fireside Chat’ at..
05/03/202407:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/03/202422:00GLOBEFirst Wave BioPharma, Inc. to Raise Approximately $4.0..
13/02/202421:00GLOBEFirst Wave BioPharma CEO to Present at the BIO CEO &..
23/01/202421:00GLOBEFirst Wave BioPharma to Present at the DealFlow MicroCap..
19/01/202406:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
18/01/202406:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/01/202421:00GLOBEFirst Wave BioPharma CEO to Present at the Sequire Investor..
09/01/202407:14EDGAR2Form S-3 - Registration statement under Securities Act of..
05/01/202407:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202407:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202422:22EDGAR2Form 8-K - Current report
04/01/202420:00GLOBEFirst Wave BioPharma Chairman and CEO Issues Letter to..
04/01/202409:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202302:21EDGAR2Form RW - Registration Withdrawal Request
28/12/202307:23EDGAR2Form 8-K - Current report
28/12/202301:55GLOBEFirst Wave BioPharma Announces Exercise of Warrants and..
27/12/202322:04EDGAR2Form S-1/A - General form for registration of securities..
27/12/202320:15EDGAR2Form 8-K - Current report
27/12/202320:00GLOBEFirst Wave BioPharma Announces Streamlining of Clinical..
18/12/202321:00EDGAR2Form 8-K - Current report
18/12/202320:00GLOBEFirst Wave BioPharma Announces Entry into Term Sheet for..
16/12/202311:48EDGAR2Form S-1/A - General form for registration of securities..
14/12/202323:15EDGAR2Form 8-K - Current report
14/12/202323:15GLOBEFirst Wave BioPharma Announces 1-for-20 Reverse Stock Split..
06/12/202321:00GLOBEFirst Wave BioPharma to Participate in BIO Partnering @JPM..
05/12/202321:00GLOBEFirst Wave BioPharma CEO James Sapirstein to Moderate Panel..
14/11/202306:20EDGAR2Form DEF 14A - Other definitive proxy statements
14/11/202306:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202305:51EDGAR2Form S-1 - General form for registration of securities under..
01/11/202306:24EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
01/11/202306:21EDGAR2Form 8-K - Current report
13/10/202306:06EDGAR2Form PRE 14A - Other preliminary proxy statements
11/10/202305:06EDGAR2Form 8-K/A - Current report: [Amend]
10/10/202320:00GLOBEDate and Time Announced for First Wave BioPharma CEO James..
07/10/202305:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202320:00GLOBEFirst Wave BioPharma CEO James Sapirstein to Present at the..
02/10/202322:20EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22/09/202322:38EDGAR2Form S-3 - Registration statement under Securities Act of..
16/09/202305:05EDGAR2Form 8-K - Current report
15/09/202321:45GLOBEFirst Wave BioPharma To Present at the BIO Investor Forum
14/09/202323:43GLOBEFirst Wave BioPharma Announces Exercise of Warrants and..
14/09/202319:19EDGAR2Form 8-K - Current report

최근 히스토리

Delayed Upgrade Clock